Fourth Vital
Inspired by my mother's loss to preventable kidney failure, I founded Fourth Vital, an Oakland-based Medtech startup. We craft AI-driven early-warning systems for chronic kidney disease (CKD), aiming to save over $125 billion annually in U.S. hospital costs and dramatically improve patient outcomes. Our SaaS solution predicts CKD much earlier than current methods. We've launched in Canada and have a global waiting list of clinics.
Fourth Vital
Inspired by my mother's loss to preventable kidney failure, I founded Fourth Vital, an Oakland-based Medtech startup. We craft AI-driven early-warning systems for chronic kidney disease (CKD), aiming to save over $125 billion annually in U.S. hospital costs and dramatically improve patient outcomes. Our SaaS solution predicts CKD much earlier than current methods. We've launched in Canada and have a global waiting list of clinics.
TL;DR
Focus: AI-driven early detection and prediction of chronic kidney disease (CKD)
Product: SaaS early-warning system using non-invasive, longitudinal at-home sensing and integrated physiological/contextual biomarkers
Headquarters: Oakland, California, United States
Founder / CEO: Patañjali Chary
Funding signal: Non-equity assistance round announced 2025-04-16; investor listed as LvlUp Ventures
Team size: 6 employees
Company Overview
Problem Domain
Underdiagnosis and late detection of chronic kidney disease (CKD); upstream kidney-risk detection gap.
Industry
Medtech
Tech Stack
Funding Track Record
Investor Signal
“LvlUp Ventures (listed as funder for the 2025 non-equity assistance round)”